Skip to content

Insider · CIK 0001722780

Rodney James Williams

director

Files at ZOMDF (Zomedica Corp.). First filing -, latest -.

In brief

Rodney James Williams files SEC Form 4 as director at ZOMDF (Zomedica Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Rodney James Williams has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 17, 2025ZOMDF
Zomedica Corp.
AGrant or award
Stock Appreciation Rightderivative
+1,975,033$0.00$01,975,033Nov 18, 2025
Nov 10, 2024ZOMDF
Zomedica Corp.
AGrant or award
Stock Appreciation Rightsderivative
+1,975,033$0.00$01,975,033Nov 26, 2024

Questions about Rodney James Williams

Answered from the filings on this page, as of the latest one.

Is Rodney James Williams buying or selling?

Rodney James Williams has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Rodney James Williams's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rodney James Williams has 0.

Where does Rodney James Williams file Form 4?

Rodney James Williams has filed Form 4 at ZOMDF (Zomedica Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Rodney James Williams: insider trades and track record | InsiderTell